Endoscopes Still Contaminated After Cleaning

Washington, DC, August 5, 2015

Potentially harmful bacteria can survive on endoscopes used to examine the interior of the digestive tract, despite a multi-step cleaning and disinfecting process, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

Though endoscopes were cleaned in accordance with multi-society guidelines, viable microbes and residual contamination remained on surfaces after each stage of cleaning, according to study findings.

Researchers from Ofstead & Associates in Saint Paul, Minnesota and Mayo Clinic in Rochester, Minnesota tested samples collected from 60 encounters with 15 colonoscopes and gastroscopes used for gastrointestinal procedures after each reprocessing step to assess contamination levels. Investigators observed all reprocessing activities, using a checklist to ensure that cleaning protocols were performed in accordance with published guidelines.

Reprocessing consisted of: bedside cleaning, manual cleaning in dedicated reprocessing rooms, and automated endoscope reprocessing with a high-level disinfectant. Disinfected endoscopes were stored vertically after drying with isopropyl alcohol and forced air. When contamination levels exceeded pre-determined benchmarks for each cleaning step, technicians went beyond guidelines and repeated cleaning procedures, retesting after each attempt to reduce contamination.

Researchers performed microbial cultures and various rapid tests to detect viable organisms and organic residue that remained after each step of cleaning. Viable organisms were detected on 92 percent of devices after bedside cleaning; 46 percent after manual cleaning; 64 percent after high-level disinfection, and 9 percent after overnight storage. Rapid indicator tests detected contamination above benchmarks on 100 percent of devices after bedside cleaning; 92 percent after manual cleaning; 73 percent after high-level disinfection, and 82 percent after overnight storage.

“This study demonstrates that colonoscopes and gastroscopes can harbor residual organic material, including viable microbes, even when adherence with recommended reprocessing guidelines is verified,” said the study authors. “More research is needed to identify processes that can ensure all flexible endoscopes are free of residual contamination and viable microbes prior to patient use, including the potential use of routine monitoring with rapid indicators and microbiologic cultures. Results from this study suggest that current standards and practices may not be sufficient for detecting and removing residual contamination.”

The authors list several potential limitations of the study including that it is a single-site study and may not be generalizable nationwide. In addition, reprocessing technicians were aware of the researchers’ use of a checklist to ensure guideline compliance and therefore may have devoted more time and effort to reprocessing. Another caveat is that technicians were immediately informed about contamination that exceeded benchmarks and repeated cleaning steps--actions that are not generally part of standard practice.

Colonoscopes and gastroscopes are endoscopic devices with thin tubes, channels, and ports that are used to examine the interior of the colon and the stomach. Recent reports of multidrug-resistant infections related to contaminated duodenoscopes, which have intricate elevator mechanisms and channels that are especially difficult to clean, have raised awareness about the necessity for meticulous reprocessing of all types of endoscopes to prevent the transmission of pathogens to patients.


Notes for editors
“Persistent contamination on colonoscopes and gastroscopes detected by biologic cultures and rapid indicators despite reprocessing performed in accordance with guidelines,” by Cori L. Ofstead, Harry P. Wetzler, Evan M. Doyle, Catherine K. Rocco, Kavel H. Visrodia, Todd H. Baron, and Pritish K. Tosh appears in the American Journal of Infection Control, Volume 43, Issue 8 (August 2015).


Cori L. Ofstead, MSPH (corresponding author)
Ofstead & Associates, Saint Paul, MN; Division of Infectious Diseases, Mayo Clinic, Rochester, MN

Harry P. Wetzler, MD, MSPH
Ofstead & Associates, Saint Paul, MN

Evan M. Doyle, BS
Ofstead & Associates, Saint Paul, MN

Catherine K. Rocco, RN, MSN, CNOR
Ofstead & Associates, Saint Paul, MN

Kavel H. Visrodia, MDc,
Division of Internal Medicine, Mayo Clinic, Rochester, MN

Todd H. Baron, MD
Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC

Pritish K. Tosh, MD
Division of Infectious Diseases, Mayo Clinic, Rochester, MN

About AJIC: American Journal of Infection Control
AJIC: American Journal of Infection Control (www.ajicjournal.org) covers key topics and issues in infection control and epidemiology. Infection preventionists, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of APIC, AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention. AJIC also publishes infection control guidelines from APIC and the CDC. Published by Elsevier, AJIC is included in MEDLINE and CINAHL.

About APIC
APIC’s mission is to create a safer world through prevention of infection. The association’s more than 15,000 members direct infection prevention programs that save lives and improve the bottom line for hospitals and other healthcare facilities. APIC advances its mission through patient safety, implementation science, competencies and certification, advocacy, and data standardization. Visit APIC online at www.apic.org. Follow APIC on Twitter: http://twitter.com/apic and Facebook: www.facebook.com/APICInfectionPreventionandYou. For information on what patients and families can do, visit APIC’s Infection Prevention and You website at www.apic.org/infectionpreventionandyou.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Liz Garman
+1 202 454 2604